- Home
- BCH vs NBIX Comparison
BCH vs NBIX Comparison
Compare BCH & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCH
- NBIX
- Stock Information
- Founded
- BCH 1893
- NBIX 1992
- Country
- BCH Chile
- NBIX United States
- Employees
- BCH N/A
- NBIX N/A
- Industry
- BCH Commercial Banks
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BCH Finance
- NBIX Health Care
- Exchange
- BCH Nasdaq
- NBIX Nasdaq
- Market Cap
- BCH 15.0B
- NBIX 14.4B
- IPO Year
- BCH 2002
- NBIX 1996
- Fundamental
- Price
- BCH $34.22
- NBIX $147.38
- Analyst Decision
- BCH Hold
- NBIX Strong Buy
- Analyst Count
- BCH 2
- NBIX 18
- Target Price
- BCH $28.00
- NBIX $165.78
- AVG Volume (30 Days)
- BCH 319.6K
- NBIX 810.0K
- Earning Date
- BCH 10-30-2025
- NBIX 10-28-2025
- Dividend Yield
- BCH 4.59%
- NBIX N/A
- EPS Growth
- BCH N/A
- NBIX 12.87
- EPS
- BCH 0.01
- NBIX 4.20
- Revenue
- BCH $2,793,481,720.00
- NBIX $2,682,700,000.00
- Revenue This Year
- BCH $18.25
- NBIX $21.00
- Revenue Next Year
- BCH $5.09
- NBIX $14.77
- P/E Ratio
- BCH $13.53
- NBIX $35.10
- Revenue Growth
- BCH N/A
- NBIX 19.61
- 52 Week Low
- BCH $22.06
- NBIX $84.23
- 52 Week High
- BCH $34.40
- NBIX $154.61
- Technical
- Relative Strength Index (RSI)
- BCH 74.44
- NBIX 64.61
- Support Level
- BCH $32.78
- NBIX $136.71
- Resistance Level
- BCH $33.24
- NBIX $144.65
- Average True Range (ATR)
- BCH 0.56
- NBIX 3.01
- MACD
- BCH 0.19
- NBIX 0.87
- Stochastic Oscillator
- BCH 95.26
- NBIX 81.88
About BCH Banco De Chile ADS
Operating under three separate brand names (Banco de Chile, Banco Edwards-Citi, and Banco CrediChile), Banco de Chile is the second largest in the country by loans and third largest by deposits. Banco de Chile generates most of its net interest income (roughly 60% of total revenue) from its mortgage, unsecured consumer credit lines, and commercial loans, with 25% of its outstanding loans being made to firms with more than 10,000 million CLP in revenue. Outside of its banking business, Banco de Chile is the largest asset manager in the country and one of the largest security brokerages, supporting its substantial fee-based revenue.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.